Candriam Equities L Oncology Impact N-H/ LU1864482606 /
| NAV23/01/2025 | Chg.+1.6000 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 190.0100EUR | +0.85% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | 2.32 | -4.01 | -2.90 | 8.30 | -0.06 | -0.60 | -3.54 | 4.72 | 7.66 | 4.62 | - |
| 2020 | -1.76 | -5.59 | -3.73 | 11.79 | 8.33 | 1.21 | 4.23 | 1.95 | 3.27 | -2.43 | 5.56 | 3.59 | +28.13% |
| 2021 | 0.38 | -4.35 | -0.36 | 2.12 | -0.02 | 3.32 | -1.15 | 5.38 | -3.98 | 3.20 | -6.53 | 3.69 | +0.97% |
| 2022 | -10.70 | -2.01 | 4.22 | -6.11 | -1.64 | -0.41 | 4.08 | -3.52 | -5.26 | 6.52 | 5.58 | -3.92 | -13.78% |
| 2023 | 1.78 | -4.18 | 1.04 | 2.55 | -2.90 | -0.23 | 0.61 | -2.33 | -5.50 | -6.63 | 8.84 | 5.41 | -2.62% |
| 2024 | 1.12 | 3.86 | 1.26 | -3.65 | 2.18 | 0.93 | 5.45 | 3.87 | -3.33 | -5.88 | -2.49 | -7.08 | - |
| 2025 | 3.09 | - | - | - | - | - | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 12.31% | 12.93% | 12.04% | 14.67% | 17.22% |
| Ratio de Sharpe | 4.83 | -1.77 | -0.41 | -0.34 | -0.09 |
| Le meilleur mois | +3.09% | +5.45% | +5.45% | +8.84% | +11.79% |
| Le plus défavorable mois | -7.08% | -7.08% | -7.08% | -10.70% | -10.70% |
| Perte maximale | -2.86% | -18.25% | -18.25% | -23.26% | -31.22% |
| Surperformance | - | - | - | - | - |
Toutes les cotations dans EUR
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.8501 | +1.26% | +5.64% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,409.3501 | +1.39% | +6.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,167.8501 | +3.75% | +14.34% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,508.6200 | +0.94% | +4.63% | |
| Candriam Equities L Oncology Imp... | paying dividend | 18,932.0000 | -2.59% | -2.78% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,954.3500 | -0.92% | -3.07% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,791.9000 | +4.07% | +20.07% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.0000 | -1.84% | -5.77% | |
| Candriam Equities L Oncology Imp... | reinvestment | 238.7100 | +4.18% | +10.64% | |
| Candriam Equities L Oncology Imp... | paying dividend | 219.8100 | 0.00% | +1.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 179.0200 | +0.85% | +4.33% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.2600 | +3.64% | +13.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 254.3800 | +5.06% | +13.47% | |
| Candriam Equities L Oncology Imp... | reinvestment | 190.0100 | -2.24% | -6.88% | |
| Candriam Equities L Oncology Imp... | reinvestment | 268.4300 | +0.84% | +4.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 179.5000 | -0.95% | -3.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,700.3301 | +0.94% | +4.63% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.0500 | +0.33% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 255.3900 | 0.00% | +1.73% |
Performance
| CAD | +3.09% | ||
|---|---|---|---|
| 6 Mois | -10.79% | ||
| 1 An | -2.24% | ||
| 3 Ans | -6.88% | ||
| 5 Ans | +6.01% | ||
| Depuis le début | +26.67% | ||
| Année | |||
| 2023 | -2.62% | ||
| 2022 | -13.78% | ||
| 2021 | +0.97% | ||
| 2020 | +28.13% | ||